Cannabis Law Report

JANUARY 26, 2022

The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need. Our promising Phase 3 results lead us to apply for the Innovation Passport. Berra Yazar-Klosinski, Ph.D.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Peninsula Alternative Health

MAY 15, 2019

Cancer Israeli scientists have explained what happens when specific strains of cannabis interact with specific types of cancer cells. The challenging part is that every individual strain is a different medicine and every individual cancer is a different disease. These symptoms can be unbearable for both patients and their caregivers.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Medicinal Marijuana Association

AUGUST 27, 2019

Mechoulam’s life path, but also the lives of millions of patients around the world – the ability to isolate the active substance in cannabis formed the foundation for an entire industry basedsolely on a single plant and the variations within its’ strains. Mechoulam and his team not only changed Prof. Signs of Prof.

Research and Development 66

Research and Development Clinical Trials Patients Epilepsy 66

Canna Care Docs

DECEMBER 16, 2020

The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. The staff at your dispensary can help you find the product that’s right for you. Chronic pain. Multiple sclerosis.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

CannaTech

SEPTEMBER 16, 2018

Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Shedding Stigma and Promoting Patient Access.

Education 66

Education Medicine Clinical Trials Patients 66

Otherside Farms

APRIL 14, 2020

In another study, people dealing with epilepsy were given 200-300mg of CBD daily and began to experience fewer seizures. Figi was given a tincture made from a specific cannabis strain that has high levels of CBD and low THC levels; the strain was later christened Charlotte’s Web. In June of 2019, the FDA in the U.S.

CBD 52

CBD Research and Development Sleep Clinical Trials 52

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. In a 47 acre greenhouse – close to the size of 42 football fields – GW is developing and delivering strains of medicinal cannabis.

Research and Development 40

Research and Development Epilepsy Clinical Trials Treatment 40

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

Ultimately, cannabis for mental health seems to boil down to questions of individual patient suitability. There are some strains of marijuana with very high CBD concentration and very little to virtually no THC content. It’s also possible for altered states to have healing or beneficial effects on others.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Alchimia

FEBRUARY 1, 2022

This molecule, which has found huge popularity in recent years due to its therapeutic potential, has led not only the scientific community to focus on its study, but also seed banks to strive to create new varieties rich in CBD, strains with different THC/CBD ratios designed to meet the needs of a growing public. Drowsiness. Mild fatigue.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

This entails exposing THC-rich strains of cannabis to UV light at extreme temperatures to dry out the cannabis. Here are some of the most common effects CBN may have on patients: Wound Healing and Anti-Inflammatory Properties. CBN is believed to relieve symptoms of conditions in which seizures are a symptom, including epilepsy.

Sleep 94

Sleep Cannabinoids THC CBD 94

Cannabis Law Report

JULY 15, 2022

“It’s very important from our perspective to ensure that the Australian patient gets medicine first. The first medicinal cannabis ‘mother’ plants are expected to be imported from Israel within a month, with manufacturing scheduled to begin within the first half of this year, to supply 5,000 Australian patients.

Medicine 52

Medicine Patients Media Supply Chain 52

The Cannigma

DECEMBER 22, 2021

It doesn’t mean, necessarily, that the market should go to full legalization within a year or two, because it won’t happen so fast, but you can have more patients with other medical indications that were not given cannabis before. Obviously, that means that there are more patients and there are more products to sell.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

SMPL

MAY 26, 2020

After two years of tracking down high-CBD pot plants and building momentum, the group began to devise ways to persuade more farmers to grow strains with CBD — which had largely been bred out of American pot since it doesn’t get you high. Both pledged to keep their strains available for other growers at cheap prices. (Mr.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

MARCH 12, 2021

But sometimes one unintended consequence of adult-use legalization is that the market no longer caters to medical patients. So, you have this attempt to legitimize healthcare and to adopt standards, to do things in a more scientific way, and in a more credible way, for patients and for industry. It’s a non-trivial issue.

Legalization 128

Legalization Patients Education Dispensary 128

Green Relief

MAY 13, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40